Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Obesity, 06/18/09
Ravussin E et al. - The results support further development of pramlintide/metreleptin as a novel, integrated neurohormonal approach to obesity pharmacotherapy.
Related Articles
A Pilot Trial of Pramlintide Home Usage in Adolescents With Type 1 Diabetes
Pediatrics, 11/09/09
Relevance Score: 84%
Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Polypill: the evidence and the promise
Current Opinion in Lipidology, 12/15/09
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Visceral adipose tissue in children and adolescents: a review
Nutrition Research Reviews, 12/15/09
Is the use of resveratrol in the treatment and prevention of obesity premature?
Nutrition Research Reviews, 12/15/09
Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes
Annals of Internal Medicine, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


